A major clinical trial has become the first to show benefits of immunotherapy in prostate cancer – for some men with advanced, otherwise untreatable disease. Researchers showed that a subset of men who had run out of all existing options for treatment survived much longer than expected when taking immunotherapy.
ASCO 2018: Major Trial is First to Show Benefits of Immunotherapy in Some Men with Prostate Cancer
source: The Institute of Cancer Research